Skip to content
DraconiticResearch
Search Sources API
181,686 studies31 sourcesUpdated 39 min ago
Peer-reviewedCC BY-NC 4.0The European Journal of Public Health

Population-level impact of Pre-exposure Prophylaxis (PrEP) on HIV incidence in Portugal, 2012-2024

Abstract

Background: Portugal maintains one of Europe’s highest HIV incidence rates (8.2 per 100000 in 2023), disproportionately affecting MSM. Despite achieving UNAIDS 95-95-95 treatment targets, prevention gaps persist. PrEP was integrated into the National Health Service in 2018-2019, reaching 7694 users by 2024. To date, no nationwide study has assessed PrEP’s population-level impact in Portugal, a setting characterized by comprehensive treatment-as-prevention coverage and still-limited PrEP uptake.

Methods: We conducted a nationwide interrupted time series analysis using mandatory surveillance data from January 2012 through December 2024 (16428 diagnoses). Segmented quasi-Poisson regression with July 2019 as the intervention breakpoint was used to estimate immediate level changes and slope modifications. Stratified analyses explored heterogeneity by transmission mode, nationality, age group, and geographic region.

Results: A pre-existing 5.5% annual decline was observed (RR = 0.9953, p < 0.001). Following PrEP implementation, an 11% immediate reduction occurred (RR = 0.89, p = 0.060) with mean monthly diagnoses declining from 122.2 to 82.3. Stratified analyses revealed significant reductions among MSM (RR = 0.85, p = 0.015), Portuguese nationals (RR = 0.83, p = 0.003), and individuals aged 15-24 years (RR = 0.69, p < 0.001). No effects were observed among non-Portuguese nationals (RR = 1.02, p = 0.770) or Lisbon metropolitan region (RR = 0.95, p = 0.465) despite concentrated services.

Conclusions: PrEP generated benefits among target populations with direct access. Observed heterogeneity appears consistent with structural barriers affecting migrants and geographic disparities. In Portugal, the hospital-centred delivery model may have constrained equitable territorial reach. Policy changes include integration into primary care, expansion of community-based distribution, culturally adapted services, and strengthened confidentiality and access guarantees, irrespective of administrative status.

Key messages: • Portugal’s PrEP program reduced HIV diagnoses significantly among MSM, Portuguese nationals, and youth, but overall modest impact reflects insufficient coverage.

• Disparities in PrEP effectiveness across populations reveal implementation barriers that must be addressed to achieve equitable HIV prevention and epidemic control.

Related

  1. Impact of HIV Pre‐Exposure Prophylaxis on HIV Incidence and Hepatitis B Outcomes Among Sex Workers Living With Hepatitis B: A Modelling Analysis in Côte D'Ivoire
    Amir M. Mohareb, Arthur Y. Kim, Menan Gérard Kouamé +10
    Journal of the International AIDS SocietyPeer-reviewedCC BY 4.0Full textInfectious diseasePMCEurope PMC
  2. Modeling the health and economic impact of scaling up monthly oral pre-exposure prophylaxis alone or alongside injectable Lenacapavir in Kenya and South Africa
    A. Malhotra, N. Patel, D. Kaftan +3
    medRxivPreprintCC BYFull textEpidemiology & public healthmedRxiv
  3. Risky sexual behaviors and associated factors among adolescent girls and young women in the context of HIV prevention pre-exposure prophylaxis in Tanzania: Analysis of the Tanzania HIV Impact Survey 2022–2023
    Magreth Thadei Mwakilasa, Deodatus Kakoko, John Gilmore +1
    PLOS Global Public HealthPeer-reviewedCC BYFull textMicrobiologyEpidemiology & public healthPLOSEurope PMC
  4. Targeted Deployment of Long-Acting HIV Pre-Exposure Prophylaxis in sub-Saharan Africa: Modelled Impact on Infections and Programme Costs to 2050
    T. B. Hallett, S. Kretschmer, M. Dybul
    medRxivPreprintCC BYFull textEpidemiology & public healthmedRxiv
  5. Real‐World Survival Outcomes of Venetoclax Combination Therapies in Acute Myeloid Leukemia: Impact of Minimal Residual Disease Status and Antifungal Prophylaxis
    Mariarita Sciumè, Alessandro Bosi, Alfredo Marchetti +7
    Hematological oncologyPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
BibTeX
@article{neves2026populationlevel,
  title = {{Population-level impact of Pre-exposure Prophylaxis (PrEP) on HIV incidence in Portugal, 2012-2024}},
  author = {D Neves and JT Correia and MI Ramalho},
  journal = {The European Journal of Public Health},
  year = {2026},
  month = oct,
  doi = {10.1093/eurpub/ckag169.516},
  url = {https://doi.org/10.1093/eurpub/ckag169.516},
  note = {CC BY-NC 4.0},
}
RIS
TY  - JOUR
TI  - Population-level impact of Pre-exposure Prophylaxis (PrEP) on HIV incidence in Portugal, 2012-2024
AU  - D Neves
AU  - JT Correia
AU  - MI Ramalho
PY  - 2026
DA  - 2026/10/01
JO  - The European Journal of Public Health
DO  - 10.1093/eurpub/ckag169.516
UR  - https://doi.org/10.1093/eurpub/ckag169.516
AB  - Background: Portugal maintains one of Europe’s highest HIV incidence rates (8.2 per 100000 in 2023), disproportionately affecting MSM. Despite achieving UNAIDS 95-95-95 treatment targets, prevention gaps persist. PrEP was integrated into the National Health Service in 2018-2019, reaching 7694 users by 2024. To date, no nationwide study has assessed PrEP’s population-level impact in Portugal, a setting characterized by comprehensive treatment-as-prevention coverage and still-limited PrEP uptake.  Methods: We conducted a nationwide interrupted time series analysis using mandatory surveillance data from January 2012 through December 2024 (16428 diagnoses). Segmented quasi-Poisson regression with July 2019 as the intervention breakpoint was used to estimate immediate level changes and slope modifications. Stratified analyses explored heterogeneity by transmission mode, nationality, age group, and geographic region.  Results: A pre-existing 5.5% annual decline was observed (RR = 0.9953, p < 0.001). Following PrEP implementation, an 11% immediate reduction occurred (RR = 0.89, p = 0.060) with mean monthly diagnoses declining from 122.2 to 82.3. Stratified analyses revealed significant reductions among MSM (RR = 0.85, p = 0.015), Portuguese nationals (RR = 0.83, p = 0.003), and individuals aged 15-24 years (RR = 0.69, p < 0.001). No effects were observed among non-Portuguese nationals (RR = 1.02, p = 0.770) or Lisbon metropolitan region (RR = 0.95, p = 0.465) despite concentrated services.  Conclusions: PrEP generated benefits among target populations with direct access. Observed heterogeneity appears consistent with structural barriers affecting migrants and geographic disparities. In Portugal, the hospital-centred delivery model may have constrained equitable territorial reach. Policy changes include integration into primary care, expansion of community-based distribution, culturally adapted services, and strengthened confidentiality and access guarantees, irrespective of administrative status.  Key messages: • Portugal’s PrEP program reduced HIV diagnoses significantly among MSM, Portuguese nationals, and youth, but overall modest impact reflects insufficient coverage.  • Disparities in PrEP effectiveness across populations reveal implementation barriers that must be addressed to achieve equitable HIV prevention and epidemic control.
SN  - 1101-1262
SN  - 1464-360X
ER  -